Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-07-005817
Filing Date
2007-03-16
Accepted
2007-03-15 18:14:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)(3) SUPPLEMENT 1 prospectussupplement.htm 424B3 54878
2 BIOSANTE LOGO biosantelogo6.jpg GRAPHIC 12999
  Complete submission text file 0001140361-07-005817.txt   74436
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-136852 | Film No.: 07697633
SIC: 2836 Biological Products, (No Diagnostic Substances)